Event
OCT New England
October 15 - October 16, 2025
Boston, Mass.
This year’s Outsourcing in Clinical Trials New England event will boast 4 tracks on Clinical Operations and Outsourcing, Clinical Technology and Innovation, Rare Diseases, and Patient Recruitment and Engagement, meaning for anyone involved in the operational aspects of running a clinical trial, there truly is something for everyone.
The 17th Annual Outsourcing in Clinical Trials New England event will bring together clinical trial professionals from big and small biopharma to uncover new technologies and processes, to optimize their clinical and outsourcing operations.
This two day program will feature four streams on Clinical Operations and Outsourcing, Clinical Technology and Innovation, Patient Recruitment and Engagement, and Rare Diseases, with a mixture of case studies, panel discussions and workshops looking at optimizing your clinical trial strategy. We will explore topics including diversity and inclusion in clinical trials, choosing and working with vendors, the potential uses of AI to increase efficiency in clinical trials, patient centricity in clinical trials, and more. Register now to book your place at the conference.
Meet us onsite at our booth #73 and join our session on Thursday, October 16 at 11:30a.m. where Kerri McCaul Claus, VP, FSP Biometrics, Parexel and Allison Covucci, Senior Director, Statistical Programming at Bristol Myers Squibb will speak on "Strength meets agility: Co-developing a framework for seamless FSO to FSP transition".
Kerri McCaul-Claus
Vice President, Head of FSP Biometrics
Thursday, October 16 from 11:30 – 12:00p.m.
Title – Strength meets agility: Co-developing a framework for seamless FSO to FSP transition
Big pharma is a battleship in a speedboat world. FSP outsourcing offers the agility to cut through traditional development timelines and chart a faster course to patients. In this presentation, Parexel will share how they partnered with Bristol Myers Squibb (BMS) to make a strategic shift, transitioning from a predominantly full-service outsourcing model to a functional service provider model. This involved redefining traditional roles, innovating tasks and responsibilities, and talent redeployment in support of pipeline priorities.
The presenters will discuss the strategic considerations and benefits of this transition, demonstrating how through a collaborative partnership, they worked to enhance BMS’ clinical trial operations, creating resource efficiencies, increasing agility, and optimizing clinical operations across their global portfolio. This presentation will offer valuable insights for companies seeking to adapt their outsourcing strategies to meet the demands of today's complex and rapidly changing drug development environment.
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.